Medreich Limited — Glucosamine Exporter Profile
Indian Pharmaceutical Exporter · #3 for Glucosamine · $1.4M export value · DGFT Verified
Medreich Limited is the #3 Indian exporter of Glucosamine with $1.4M in export value and 27 verified shipments. Medreich Limited holds a 10.2% market share in Glucosamine exports across 2 countries. The company exports 42 pharmaceutical products worth $224.8M across 15 therapeutic categories.
Medreich Limited — Glucosamine Export Profile: Buyers & Destinations
Where Does Medreich Limited Export Glucosamine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SINGAPORE | $1.0M | 23 | 88.4% |
| MALAYSIA | $136.0K | 4 | 11.6% |
Medreich Limited exports Glucosamine to 2 countries. The largest destination is SINGAPORE accounting for 88.4% of Medreich Limited's Glucosamine shipments. These destinations reflect Medreich Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Glucosamine from Medreich Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PHARMAZEN MEDICALS PTE LTD., | SINGAPORE | $712.2K | 15 |
| PHARMAZEN MEDICALS PTE LIMITED | SINGAPORE | $219.7K | 6 |
| HEALOL PHARMACEUTICALS SDN BHD | MALAYSIA | $136.0K | 4 |
| PHARMAZEN MEDICALS PTE LTD | SINGAPORE | $100.0K | 2 |
Medreich Limited supplies Glucosamine to 4 buyers globally. The largest buyer is PHARMAZEN MEDICALS PTE LTD., (SINGAPORE), followed by PHARMAZEN MEDICALS PTE LIMITED (SINGAPORE) and HEALOL PHARMACEUTICALS SDN BHD (MALAYSIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Glucosamine Export Value and How Much Does Medreich Limited Contribute?
India exported $9.9M worth of Glucosamine through 657 shipments from 118 suppliers to 65 countries, serving 197 buyers globally. Medreich Limited contributes $1.4M to this total, accounting for 10.2% of India's Glucosamine exports. Medreich Limited ships Glucosamine to 2 countries through 4 buyers.
What Is the Average Shipment Value for Medreich Limited's Glucosamine Exports?
Medreich Limited's average Glucosamine shipment value is $50.0K per consignment, based on 27 shipments totaling $1.4M. The largest destination is SINGAPORE (88.4% of Medreich Limited's Glucosamine exports).
How Does Medreich Limited Compare to Other Indian Glucosamine Exporters?
Medreich Limited ranks #3 among 118 Indian Glucosamine exporters with a 10.2% market share. The top 3 exporters are PANACEA BIOTEC PHARMA LIMITED ($1.8M), MEDREICH LIMITED ($1.4M), MEDINOMICS HEALTH CARE PRIVATE LIMITED ($1.2M). Medreich Limited processed 27 shipments to 2 destination countries.
What Glucosamine Formulations Does Medreich Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| GLUCOSAMINE 500MG CAPSULES (CARTIFLEX 50 | $412.2K | 9 |
| GLUCOSAMINE 1500MG SUSTAINED RELEASE TAB | $122.4K | 5 |
| GLUCOSAMINE 500MG CAPSULES CARTIFLEX 50 | $100.0K | 2 |
| GLUCOSAMINE 500MG CAPSULES CARTIFLEX 500MG CAPSULES 100X10S 4890 PACKS | $50.0K | 1 |
| GLUCOSAMINE 500MG CAPSULES CARTIFLEX 500MG CAPSULES 100X10S 4872 PACKS | $50.0K | 1 |
| GLUCOSAMINE 500MG CAPSULES (CARTIFLEX 500MG CAPSULES) 100X10S (4872 PACKS) | $50.0K | 1 |
| GLUCOSAMINE 500MG CAPSULES (CARTIFLEX 500MG CAPSULES) 100X10S (4914 PACKS)NOS | $50.0K | 1 |
| GLUCOSAMINE 500MG CAPSULES (CARTIFLEX 500MG CAPSULE) 100X10S (4807 PACKS) | $50.0K | 1 |
| GLUCOSAMINE 500MG CAPSULES (CARTIFLEX 500MG CAPSULES) 100X10S (4860 PACKS)NOS | $50.0K | 1 |
| GLUCOSAMINE 500MG CAPSULES (CARTIFLEX 500MG CAPSULES) 100X10S (4904 PACKS) | $50.0K | 1 |
Medreich Limited exports 14 distinct Glucosamine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is GLUCOSAMINE 500MG CAPSULES (CARTIFLEX 50 with 9 shipments worth $412.2K.
How Does Medreich Limited Compare to Nearest Glucosamine Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | PANACEA BIOTEC PHARMA LIMITED | $1.8M | 41 | 1 | $45.1K |
| 3 | MEDREICH LIMITED ★ | $1.4M | 27 | 2 | $50.0K |
| 2 | MEDINOMICS HEALTH CARE PRIVATE LIMITED | $1.2M | 24 | 1 | $50.0K |
| 5 | TROIKAA PHARMACEUTICALS LIMITED | $946.1K | 41 | 7 | $23.1K |
Medreich Limited ranks #3 among 118 Indian Glucosamine exporters. Average shipment value of $50.0K compared to the market average of $84.0K. The closest competitors by value are PANACEA BIOTEC PHARMA LIMITED and MEDINOMICS HEALTH CARE PRIVATE LIMITED.
Which Indian Ports Ship Glucosamine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 57 | 8.7% |
| CHENNAI AIR CARGO ACC (INMAA4) | 45 | 6.8% |
| CHENNAI AIR | 41 | 6.2% |
| CHENNAI SEA (INMAA1) | 39 | 5.9% |
| DELHI AIR | 36 | 5.5% |
| MUNDRA SEA | 34 | 5.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 29 | 4.4% |
| NHAVA SHEVA SEA (INNSA1) | 28 | 4.3% |
What Other Nutritional Supplements Products Does Medreich Limited Export?
Medreich Limited also exports these nutritional supplements products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Medreich Limited's Glucosamine Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medreich Limited. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)
Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk to Indian companies, as higher tariffs could render low-margin generic drugs unprofitable, leading to market exits and exacerbating drug shortages in the US. (cfo.economictimes.indiatimes.com)
The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable development for Medreich. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing immediate cost relief and enhancing market access. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, creating new opportunities for companies like Medreich to expand their presence in the EU market. (en.wikipedia.org)
Medreich Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements that companies must adhere to for market access. Recent regulatory frameworks have increased compliance costs by an average of 18.7%, leading to a 15.2% reduction in export volumes to the US in the first quarter of 2025. (transdatanexus.com)
For Medreich Limited, maintaining compliance with these evolving standards is crucial to sustaining and expanding its export markets. Investments in quality assurance, regular audits, and staying abreast of regulatory changes are essential strategies to navigate this complex landscape.
About Medreich Limited
Medreich Limited exports 42 products worth $224.8M. Beyond Glucosamine, top products include Amoxicillin, Potassium, Flucloxacillin, Rosuvastatin, Atorvastatin. View the complete Medreich Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Glucosamine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Glucosamine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medreich Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 27 individual customs records matching Medreich Limited exporting Glucosamine, covering 14 formulations to 2 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 65+ countries, 197+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Glucosamine Export Data from Medreich Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medreich Limited's Glucosamine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medreich Limited
Full Company Profile →
42 products · $224.8M total trade · 15 categories
Glucosamine Stats
Company Overview
Top Products by Medreich Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medreich Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Glucosamine. For current shipment-level data, contact TransData Nexus.